http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022111010-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1796
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38
filingDate 2021-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81f8b0f56086e4cc1097850f8f0a4717
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64f7362a82d5c8807bc7940d03aa67b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58e2ea7d87f07a64c3daf723e3af6a29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01b69be148e702187faee1a00a12fb1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b489e83958b244abfcb173243f2b35a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a08ff9afe793717b8d56e380c7873e9
publicationDate 2022-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022111010-A1
titleOfInvention Long-acting glp-1r agonist as a therapy of neurological and neurodegenerative conditions
abstract The present invention relates to compositions and methods for treating neurodegenerative conditions using GLP-1r agonists. In certain embodiments, long-acting GLP-1r agonists have neuroprotective and disease modifying effects on the central nervous system.
priorityDate 2015-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5363269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5364430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2770225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID245861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53716604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16186314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749

Total number of triples: 85.